Another trillion track! The first five-year plan for the bio-economy has been released, and many places have been deployed, and these areas are expected to benefit

        On the morning of May 10, the National Development and Reform Commission issued the "14th Five-Year Plan for Bioeconomic Development" (hereinafter referred to as the "Plan"), which is my country's first five-year bioeconomy plan. This marks that the bioeconomy has become a new economic form. Biotechnology and biological resources are the core elements of the bioeconomy. In the future, the bioeconomy will focus on the development of biomedicine, bioagriculture, and green and low-carbon biomass replacement applications, and strengthen the four major areas of national biosecurity risk prevention and control and governance system construction. very broad.

        Previously, the "14th Five-Year Plan" and the 2035 Vision Outline proposed to promote the integration and innovation of biotechnology and information technology, accelerate the development of biomedicine, biobreeding, biomaterials, bioenergy and other industries, and make the bioeconomy bigger and stronger.

        In this regard, experts pointed out that with the entry of diversified financial resources and social capital, the new generation of bio-economy will thrive, and the trillion-level market is expected to develop rapidly. Some institutions even predict that the industrial scale of bio-economy will reach 40 trillion yuan in the future, becoming the next important growth point of China's economy.

        5月10日上午，国家发展改革委印发《“十四五”生物经济发展规划》（以下简称“规划”），这是我国首个生物经济五年规划。这标志着生物经济已经成为一种新的经济形态。生物技术和生物资源是生物经济的核心要素，未来生物经济将重点发展生物医药、生物农业、绿色低碳的生物质替代应用，加强国家生物安全风险防控和治理体系建设四大领域，发展空间十分广阔。

        此前，“十四五”规划和2035年远景目标纲要提出，推动生物技术和信息技术融合创新，加快发展生物医药、生物育种、生物材料、生物能源等产业，做大做强生物经济。

        就此，专家指出，随着多元化的金融资源和社会资本的进入，新一代生物经济将茁壮成长，万亿级别市场有望快速发展。甚至有机构预计，未来生物经济的产业规模将达40万亿元，成为中国经济下一个重要增长点。

The 14th Five-Year Plan for Bio-Economic Development was released, involving corporate listing and cultivation, vaccine research and development, etc.

        On May 10, the National Development and Reform Commission issued the "14th Five-Year Plan for Bioeconomic Development".

        The plan proposes that during the "14th Five-Year Plan" period, my country's biotechnology and bio-industry will develop rapidly, the bio-economy will become a strong driving force for high-quality development, and the construction of bio-safety risk prevention and control and governance systems will continue to be strengthened. Looking forward to 2035, in accordance with the requirements of basically realizing socialist modernization, my country's comprehensive bio-economy strength will stably rank in the forefront of the world, and it will basically form a country with leading technology level, strong industrial strength, extensive integration and application, strong resource guarantee, controllable security risks, and complete institutional system. develop a new situation.

        The plan proposes to carry out cutting-edge biotechnology innovation. Accelerate the development of high-throughput gene sequencing technology, promote the innovation of next-generation sequencing technology marked by single-molecule sequencing, and continuously improve the efficiency of gene sequencing and reduce the cost of sequencing. Strengthen the research and development of biological detection technologies such as microfluidics and high sensitivity. Promote synthetic biology technological innovation, make breakthroughs in key technologies such as computational design, high-throughput screening, high-efficiency expression, and precise regulation of biological manufacturing strains, and orderly promote new drug development, disease treatment, agricultural production, material synthesis, environmental protection, and energy supply. and new material development. Develop new technologies such as gene diagnosis and treatment, stem cell therapy, and immune cell therapy, strengthen the synergy between industry, academia, and research, accelerate the transformation and clinical application of related technologies, and promote the formation of new models of regenerative medicine and precision medicine. Deploy and carry out research on the mechanism of traditional Chinese medicine in the treatment of major diseases and the principle of acupuncture and moxibustion. Encourage the development of new technologies such as biological computing and deoxyribonucleic acid (DNA) storage.

        The plan proposes to promote the deep integration of advanced technologies such as genetic testing and biological genetics with disease prevention, carry out early screening of major diseases such as genetic diseases, birth defects, tumors, cardiovascular diseases, and metabolic diseases, and provide precise solutions and decisions for individualized treatment. support. Accelerate the iterative upgrade of vaccine R&D and production technologies, develop polyvalent and multivalent vaccines, develop new genetically engineered vaccines and therapeutic vaccines, and improve the ability to respond to major severe infectious diseases.

        The plan proposes that on the premise of respecting science, strict supervision, compliance with laws and regulations, and ensuring safety, the industrial application of biological breeding and other fields will be promoted in an orderly manner, and the supply of important agricultural products such as grain, meat, eggs, milk, and oil will be guaranteed. Orderly develop whole-genome selection, systems biology, synthetic biology, artificial intelligence and other biological breeding technologies, focus on improving the capabilities of breeding, production and processing, and popularization and application of improved varieties, and accelerate the construction of a commercial breeding innovation system. Actively promote high-quality corn and soybean grain crops with high resistance, and carry out research and scientific breeding of high-quality live pigs, white-feathered broilers, dairy cows and other livestock and aquatic products. Develop synthetic biology technology, explore and develop new foods such as "artificial protein", realize the iterative upgrade of the food industry, and reduce the pressure on environmental resources brought by traditional aquaculture.

        In addition, the plan also proposes to give full play to the role of the National Emerging Industry Venture Capital Guidance Fund and the Strategic Emerging Industry Fund, and vigorously support the development of innovative biotechnology enterprises in accordance with the principle of marketization. Encourage social capital agglomeration, use angel investment, venture capital, and foreign capital to solve the funds needed for enterprise R&D and production. Strengthen the listing and cultivation of biological enterprises, further increase the support for the listing of biological enterprises in the domestic capital market, and attract high-quality biological enterprises to be listed on the main board and the Science and Technology Innovation Board.

      “十四五”生物经济发展规划发布 涉及企业上市培育、疫苗研发等

        5月10日，国家发展改革委印发《“十四五”生物经济发展规划》。

        规划提出，“十四五”时期，我国生物技术和生物产业加快发展，生物经济成为推动高质量发展的强劲动力，生物安全风险防控和治理体系建设不断加强。展望2035年，按照基本实现社会主义现代化的要求，我国生物经济综合实力稳居国际前列，基本形成技术水平领先、产业实力雄厚、融合应用广泛、资源保障有力、安全风险可控、制度体系完备的发展新局面。

        规划提出，开展前沿生物技术创新。加快发展高通量基因测序技术，推动以单分子测序为标志的新一代测序技术创新，不断提高基因测序效率、降低测序成本。加强微流控、高灵敏等生物检测技术研发。推动合成生物学技术创新，突破生物制造菌种计算设计、高通量筛选、高效表达、精准调控等关键技术，有序推动在新药开发、疾病治疗、农业生产、物质合成、环境保护、能源供应和新材料开发等领域应用。发展基因诊疗、干细胞治疗、免疫细胞治疗等新技术，强化产学研用协同联动，加快相关技术产品转化和临床应用，推动形成再生医学和精准医学治疗新模式。部署开展中医药治疗重大疾病作用机制及针灸作用原理研究。鼓励发展生物计算、脱氧核糖核酸（DNA）存储等新技术。

        规划提出，推动基因检测、生物遗传等先进技术与疾病预防深度融合，开展遗传病、出生缺陷、肿瘤、心血管疾病、代谢疾病等重大疾病早期筛查，为个体化治疗提供精准解决方案和决策支持。加快疫苗研发生产技术迭代升级，开发多联多价疫苗，发展新型基因工程疫苗、治疗性疫苗，提高重大烈性传染病应对能力。

        规划提出，在尊重科学、严格监管、依法依规、确保安全的前提下，有序推动生物育种等领域产业化应用，保障粮食、肉蛋奶、油料等重要农产品供给。有序发展全基因组选择、系统生物学、合成生物学、人工智能等生物育种技术，着力提升良种培育、生产加工、推广应用等能力，加快构建商业化育种创新体系。积极推进高抗优质玉米、大豆粮食作物，开展优质生猪、白羽肉鸡、奶牛等禽畜和水产品良种攻关及科学饲养。发展合成生物学技术，探索研发“人造蛋白”等新型食品，实现食品工业迭代升级，降低传统养殖业带来的环境资源压力。

        此外，规划还提出，发挥国家新兴产业创业投资引导基金、战略性新兴产业基金等作用，按照市场化原则，大力支持创新型生物技术企业发展。鼓励社会资本集聚，利用天使投资、创业投资、外资力量，解决企业研发和生产所需资金。加强生物企业上市培育，进一步加大对生物企业在境内资本市场上市的支持力度，吸引优质生物企业在主板和科创板上市。